I would think well beyond that bigal.
Importantly, the report specifically says: while final pricing mechanisms are not yet completely agreed with all offtake customers spodumene pricing is expected to be revised upwards (relative to the historical norm) and would currently support pricing in the range of approximately USD $1650-$1800/dmt..."
Thats USD! Most important takeout of entire report. $3+ now I would of thought as those prices are against our CONTRACTED vols. Ill leave the upramping to the usuals.
Ann: September 2021 Quarterly Activities Report, page-9
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.09 |
Change
-0.060(1.90%) |
Mkt cap ! $9.215B | |||
| Open | High | Low | Value | Volume |
| $3.13 | $3.15 | $3.02 | $42.80M | 13.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 32656 | $3.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.10 | 149949 | 40 |
View Market Depth
| Last trade - 13.27pm 04/10/2024 (20 minute delay) ? |
| PLS (ASX) Chart |